AST-301(Aptamer Sciences)

N/A

Report date: 2024/01/12 17:54:08

Base Information

Drug NameAST-301(Aptamer Sciences)
Drug Alias NameAST-301(Aptamer Sciences)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionToll like receptor 2 modulators
TargetsToll like receptor 2
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAptamer Sciences IncNeuramedy Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAptamer Sciences IncNeuramedy Co Ltd
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A